Nonalcoholic steatohepatitis (NASH) is a significant form of chronic liver
disease in adults and children. The natural history of NASH ranges from ind
olent to endstage liver disease. Current studies are focusing on identifica
tion of histologic and/or clinical markers of progression. NASH may be an u
nderlying cause of cryptogenic cirrhosis, and the lesions of NASH may recur
in allograft livers. An expanding array of clinical conditions and pathoge
netic mechanisms have been identified, but many cases remain "idio-pathic";
lack of significant alcohol use is, by definition, common to all cases. Ne
ither clinical evaluation nor laboratory values can ensure either the diagn
osis or the exclusion of NASH, and liver biopsy interpretation continues to
be considered the "gold standard" for diagnosis. The lesions in NASH are s
imilar but not identical to those of alcoholic steatohepatitis; exact, spec
ific histologic criteria for the diagnosis are currently under discussion.
The lesions most commonly accepted for NASH include steatosis, hepatocyte b
allooning degeneration, mild diffuse lobular mixed acute and chronic inflam
mation, and perivenular, perisinusoidal collagen deposition. Zone 3 accentu
ation may be detected. Mallory's hyaline, vacuolated nuclei in periportal h
epatocytes, lobular lipogranulomas, and PAS-diastase-resistant Kupffer cell
s are common. In biopsy specimens from children, portal inflammation may be
more prominent than in adults. Progression of fibrosis may result in bridg
ing septa and cirrhosis. The lesions of steatohepatitis may be noted concur
rently with other forms of chronic Liver disease. A histological "grading a
nd staging" system has been developed to reflect the unique features of ste
atohepatitis, gradations of severity and fibrosis, and to promote uniform r
eporting of the histopathology.